Ablation of RASA2 Improves T-cell Activity in Both Solid and Liquid Tumors

Article navigation

Research Watch| November 02 2022

Online ISSN: 2159-8290

Print ISSN: 2159-8274

2022

American Association for Cancer Research

Cancer Discov (2022) 12 (11): 2491.

Abstract

RASA2 ablation increases CAR T-cell cytolytic activity and improves persistent cancer cell killing.

2022

American Association for Cancer Research

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.